{'fraction_non_alphanumeric': 0.021505376344086023, 'fraction_numerical': 0.0, 'mean_word_length': 5.131578947368421, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical results after the implementation of cell‐free fetal DNA detection in maternal plasma

Detection of cell‐free fetal DNA in maternal blood is a type of noninvasive prenatal diagnosis test (NIPT), which has already been known for some time but has not yet been introduced in most of public hospitals in Spain. How the implementation of cell‐free fetal DNA (cffDNA) in a contingent protocol has influenced the aneuploidy screening in our hospital is described.